Skip to content

Kinedrongen

Active
Private limited companyfounded 2024active for 2 yearsAntoon Catriestraat 38, 9031 Gent, BelgiumKBO/BCE: BE 1014.981.373
Summary

Kinedrongen has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €99,161 and a net result of €95,161. Its solvency ranks better than 70% of 20,612 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow ReportCompare
KinedrongenActiveChecked score 97/100
Risk analysis ReportCompare

Overview

Activity
Physiotherapy
NACE 86951
1 site
Size
€124,332total assets 2025
Equity
€99,161
Profit
€95,161
Turnover not published (micro format)
Financial health
97 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
2025 accounts filed 13 days late
Why 97lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 1.80, cash €28,974Figures for financial year 2025 (filed 13-08-2026)Equity €99,161 (79.8% of total assets)Show the evidence

Checked score

Score 2025
97 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 72% of its sector peers (NACE 86, micro)
Every signal that counts is listed under Signals.
Financial strength
Strong
Solvency 100
equity 79.8% of total assets
Liquidity 73
short-term debt 20.2% · cash 23.3%
Profitability 100
return on assets 76.5%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,124 companies, NACE 86, micro)
Last 24 months 11-2025: 0.3% 12-2025: 0.3%● unchanged vs 11-2025 01-2026: 0.3%● unchanged vs 12-2025 02-2026: 0.3%● unchanged vs 01-2026 03-2026: 0.3%● unchanged vs 02-2026 04-2026: 0.4%▲ +0.1 percentage points vs 03-2026 05-2026: 0.4%● unchanged vs 04-2026 06-2026: 0.4%● unchanged vs 05-2026highest value 07-2026: 0.4%● unchanged vs 06-2026 08-2026: 0.4%● unchanged vs 07-2026 09-2026: < 0.1%▼ -0.4 percentage points vs 08-2026lowest value 10-2026: < 0.1%● unchanged vs 09-2026
Credit of up to €9,000 on 30-day terms, only on tighter conditions: young company (under 3 years) without a track record
Liquidity ample (current ratio 1.8, above the usual 1.5; short-term debt: 20.2% and cash: 23.3% of total assets), and 20.2% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 82% on solvency, 54% on liquidity and 80% on profitability.

The bankruptcy probability was computed on 26-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises risk
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 1.80, cash €28,974
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed 13-08-2026)
NBB · annual accounts
lowers risk · Equity €99,161 (79.8% of total assets)
NBB · annual accounts
raises risk · Young company
Founded in 2024, 2 years ago. Young companies fail more often than established ones; the risk is highest 2 to 8 years after founding.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 2 years 0 10 years
raises risk · 2025 accounts filed 13 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 13-08-2026, 13 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 1 filing
Deviation from the deadline
2025
13 days late
← before the deadline after the deadline →
Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2024.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. IncorporationAppointment: DE ZUTTER Thierry Leon…

Key points

  • One director decidessole director in office 1 View
  • Total assets 2025first financial year filed €124,332 View
  • Active since 2024founded 11-10-2024 2 years View

By topic

Financials

Financial year
2025
Total assets
€124,332
Profit
€95,161
Solvency
79.8%
Go to Financials

Company details

Sites
1
Legal form
Private limited company
Activity
PhysiotherapyNACE 86951
Founded
11-10-2024
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
38
Annual meeting
First Thursday of June at 19:00
Purpose
“Ambulante revalidatieactiviteiten; Kinesitherapie activiteiten; Overige menselijke…” (deed in Dutch)
Statutory auditor
No statutory auditor
Go to Articles of association

Key facts about Kinedrongen

What is the company number of Kinedrongen?
1014.981.373. In Belgium the VAT number is the company number with BE in front: BE 1014.981.373.
Where is Kinedrongen based?
The registered office is at Antoon Catriestraat 38, 9031 Gent.Company details
What does Kinedrongen do?
According to the KBO register, the main activity is physiotherapy (NACE 86951).
What is the legal form of Kinedrongen?
Private limited company (BV).
When was Kinedrongen founded?
On 11-10-2024.
Is Kinedrongen still active?
Yes, Kinedrongen is an active enterprise in the KBO register.
What is the turnover of Kinedrongen?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
Is Kinedrongen profitable?
In financial year 2025, Kinedrongen made a profit of €95,161.
Where can I find the annual accounts of Kinedrongen?
Kinedrongen filed 1 annual account with the National Bank of Belgium, for financial year 2025.

Companies related to Kinedrongen

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark Roughly what is this company worth?Value indication

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure